Al Tamimi Ammad Shanoon, Zaheer Sumbul, Ng David Chee, Osmany Saabry
Department of Radiology/Nuclear Medicine and Molecular Imaging Division, Massachusetts General Hospital/Harvard Medical School, 55 Fruit Street, White 427, Boston, MA 02114, United States.
Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore.
Oral Oncol. 2015 Nov;51(11):1047-1050. doi: 10.1016/j.oraloncology.2015.08.001. Epub 2015 Aug 24.
The only investigation to determine if a whole body FDG PET/CT scan is helpful in the evaluation of NPC is a study from Stanford. In this study, 26 patients with whole body PET/CT, were evaluated for lesions below adrenals and showed that 7.7% of distant metastases were below adrenals. Our study comparing distant metastases below diaphragm with Stanford study to evaluate the need for whole body PET/CT.
Reports of NPC patients in Singapore General Hospital were reviewed. The lesions were analyzed for total number and number below diaphragm. The lesions below the diaphragm were further analyzed if they were solitary or involved multiple areas and if any additional lesions were above diaphragm.
717 reports were included in final analysis. The number of FDG avid lesions in these reports was 709. Distant metastases represented 352 of the 709 lesions. The number of lesions below diaphragm was 152, of the lesions below diaphragm only 16 of lesions have no co-existing distant metastases above diaphragm. From these lesions, there were only 12 solitary lesions. The other 4 has concurrent metastases but all localized below diaphragm.
Compared to Stanford study, number of reports is more representative in this study and the yield is much lower (7.7% versus 2.26%). From the results of our study we can consider limiting the scan area from vertex to below diaphragm. However, the symptoms and clinical presentation of the patient will further direct the requesting physician in the area to be imaged.
唯一一项确定全身氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)是否有助于鼻咽癌(NPC)评估的研究来自斯坦福大学。在这项研究中,对26例进行全身PET/CT检查的患者肾上腺以下的病变进行了评估,结果显示7.7%的远处转移发生在肾上腺以下。我们的研究将横膈以下的远处转移与斯坦福大学的研究进行比较,以评估全身PET/CT的必要性。
回顾了新加坡总医院鼻咽癌患者的报告。分析病变的总数以及横膈以下的病变数量。如果横膈以下的病变为孤立性或累及多个区域,以及横膈以上是否有其他病变,则对这些病变进行进一步分析。
最终分析纳入了717份报告。这些报告中氟代脱氧葡萄糖摄取阳性病变的数量为709个。远处转移占709个病变中的352个。横膈以下的病变数量为152个,在横膈以下的病变中,只有16个病变在横膈以上没有并存的远处转移。在这些病变中,只有12个是孤立性病变。另外4个有并发转移,但均局限于横膈以下。
与斯坦福大学的研究相比,本研究的报告数量更具代表性,且检出率要低得多(7.7%对2.26%)。根据我们的研究结果,我们可以考虑将扫描范围限制在从头顶到横膈以下。然而,患者的症状和临床表现将进一步指导申请医生确定成像区域。